Performance of the Oncomine<sup>TM</sup> Lung cfDNA Assay for Liquid Biopsy by NGS of NSCLC Patients in Routine Laboratory Practice

Performance of the Oncomine<sup>TM</sup> Lung cfDNA Assay for Liquid Biopsy by NGS of NSCLC Patients in Routine Laboratory Practice

Targeted next-generation sequencing (NGS) based on molecular tagging technology allowed considerable improvement in the approaches of cell-free DNA (cfDNA) analysis. Previously, we demonstrated the feasibility of the Oncomine<sup>TM</sup> Lung cell-free DNA Assay (OLcfA) NGS panel when a...

Full description

Bibliographic Details
Main Authors: Giuseppa De Luca, Sonia Lastraioli, Romana Conte, Marco Mora, Carlo Genova, Giovanni Rossi, Marco Tagliamento, Simona Coco, Maria Giovanna Dal Bello, Simona Zupo, Mariella Dono
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:Applied Sciences
Subjects:
circulating tumor DNA
liquid biopsy
NGS
molecular tagging technology
NSCLC
<i>EGFR</i> Thr790Met
Online Access:https://www.mdpi.com/2076-3417/10/8/2895

Internet

https://www.mdpi.com/2076-3417/10/8/2895

Similar Items